ABT vs BHRB · P/E 25, rev $44.33B vs P/E 8.4, rev $445.0M
Abbott Laboratories (ABT) versus Burke & Herbert Financial Services Corp. Common Stock (BHRB) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Burke & Herbert Financial Services Corp. Common Stock (BHRB) is a banks - regional company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported BHRB revenue for 2025-12-31 was $445.0M. Net income was $117.3M. Revenue was up 21.5% from 2024-12-31 to 2025-12-31. BHRB currently screens at market cap $1.30B and trailing P/E 8.4.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. BHRB currently screens at market cap $1.30B and trailing P/E 8.4.
Not investment advice. Open the ABT and BHRB stock pages for the full models.
Not investment advice.